Draft Genome Sequence of the First NDM-1-ProducingProvidencia stuartiiStrain Isolated in Portugal by Manageiro, Vera et al.
Draft Genome Sequence of the First NDM-1-Producing Providencia
stuartii Strain Isolated in Portugal
Vera Manageiro,a,b Daniel A. Sampaio,c Patrícia Pereira,d Paulo Rodrigues,d Luís Vieira,c Carlos Palos,d Manuela Caniçaa
National Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr. Ricardo
Jorge, Lisbon, Portugala; Centre for the Studies of Animal Science, Institute of Agrarian and Agri-Food Sciences and Technologies, Oporto University, Oporto, Portugalb;
Innovation and Technology Unit, Department of Human Genetics, National Institute of Health, Dr. Ricardo Jorge, Lisbon, Portugalc; Hospital Beatriz Ângelo, Loures,
Portugald
We report here the draft genome sequence of the first NDM-1-producing Providencia stuartii strain isolated in Portugal. Se-
quence analyses revealed the presence of an incompatibility group A/C2 (IncA/C2) plasmid and of diverse acquired genes confer-
ring resistance to-lactams, aminoglycosides, tetracycline, macrolides, chloramphenicol, and sulfonamides. This sequence con-
tributes to the evaluation of the spread of NDM-1 producers.
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Providencia stuartii, an opportunistic pathogen typically associ-ated with urinary infections, has intrinsic resistance to antibi-
otics considered to be of last resort, such as colistin and tigecycline
(1, 2). Moreover, carbapenemase producers have been reported,
which can become of higher concern (3–5).
Five NDM-1-producing P. stuartii isolates were obtained dur-
ing an outbreak detected in a Portuguese hospital. One isolate, P.
stuartii INSRA21868, recovered from a urine sample from an 88-
year-old male patient admitted to the intensive care unit due to an
enterocutaneous fistula, was selected for genetic characterization
using whole-genome sequencing (WGS).
DNA was extracted from an overnight grown culture using the
QIAamp DNA minikit (Qiagen), according to the manufacturer’s
instructions. Libraries were prepared from 1 ng of genomic DNA
using the Nextera XT DNA sample preparation kit (Illumina),
according to the manufacturer’s instructions. WGS was per-
formed using 150-bp paired-end reads on a MiSeq (Illumina). The
sequence reads were trimmed and filtered according to quality
criteria and de novo assembled into contigs and subsequently into
scaffolds by means of CLC Genomics Workbench 8.0.1 (Qiagen,
Aarhus, Denmark).
The analysis yielded 59 contigs ranging from 246 bp to
365,814 bp, with a minimum of 100-fold coverage. The draft ge-
nome contains a total assembly length of 4,438,644 bp, with a
mean coverage of about 290-fold; the GC content was 43.1%.
All de novo contigs were searched against the GenBank data-
base nucleotide collection (nr/nt) using Mega BLAST, with seven
contigs (15/41/43/47/48/49/53) mapping against plasmid se-
quences deposited there; the remaining sequence aligned to the P.
stuartii genome (accession no. NZ_CP008920 and CP003488).
The nucleotide sequence was annotated using the NCBI Pro-
karyotic Genome Annotation Pipeline (PGAP) (http://www.ncbi
.nlm.nih.gov/genome/annotation_prok/). The numbers of anno-
tated features were as follows: 3,962 coding sequences (CDSs),
4,146 genes, 20 noncoding RNAs (ncRNAs), 4 rRNAs, and 72
tRNAs.
In silico antimicrobial resistance analyses using ResFinder ver-
sion 2.1 (6), with a threshold of 90% identity and a minimum
length of 40%, revealed genes conferring resistance to -lactams
(blaNDM-1 [contig 53], blaCMY-4 [contig 15], andblaDHA-1 [contig
53]), aminoglycosides (aac(2=)-Ia [contig 19] and armA [con-
tig 49]), tetracycline (tetB [contig 9]), macrolides (mphE and
msrE [contig 49]), chloramphenicol (catB3 [contig 2]), and
sulfonamides (sul1 [contig 49]). PlasmidFinder version 1.2 (7)
analyses revealed the presence of incompatibility group A/C2
(IncA/C2), which has been associated with a wide dissemina-
tion of blaNDM-1.
The NDM-1-encoding gene was found in the 3,360-bp-long
contig 53, with a mean coverage of about 136-fold and a GC
content of 57.9%. In the 3= region, the blaNDM-1 gene was adjacent
to a bleomycin resistance-encoding gene (bleMBL), followed by a
trpF and part of the blaDHA-1-ampR region. The ISAba125 element
upstream of blaNDM-1 was interrupted by an IS26 element. Four
plasmids harbored by different Enterobacteriaceae isolates showed
the highest identities with this genetic structure (accession num-
bers KJ187752, LN831185, JX988621, and HQ451074).
Overall, this genome sequence contributes to the evaluation
of the global molecular epidemiology and spread of NDM-1
producers.
Nucleotide sequence accessionnumbers.This whole-genome
sequencing shotgun project has been deposited at DDBJ/EMBL/
GenBank under the accession no. LGYB00000000. The version
described in this paper is version LGYB01000000.
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